Reserved for future guideline expansion
D89.89
BookmarkOther specified disorders involving the immune mechanism, not elsewhere classified
Filed alongside this entry 305
under Disorder (of)
- acantholytic L11.9
- adjustment (grief) F43.20
- adrenal (capsule) (gland) (medullary) E27.9
- adrenogenital E25.9
- adult personality (and behavior) F69
- aggressive, unsocialized F91.1
- alcohol-related F10.99
- alveolar NEC J84.09
- anaerobic glycolysis with anemia D55.29
- anxiety F41.9
- aromatic amino-acid metabolism E70.9
- arteriole NEC I77.89
- artery NEC I77.89
- attention-deficit hyperactivity (adolescent) (adult) (child) F90.9
- attention-deficit without hyperactivity (adolescent) (adult) (child) F98.8
- auditory processing (central) H93.25
- autistic F84.0
- autism spectrum F84.0
- autoimmune D89.89
- autonomic nervous system G90.9
- bereavement, persistent complex F43.81
- beta-amino-acid metabolism E72.89
- bile acid and cholesterol metabolism E78.70
- bilirubin excretion E80.6
- binge eating F50.81
- bipolar (I) (seasonal) (type 1) F31.9
- bladder N32.9
- bleeding D68.9
- blood D75.9
- body dysmorphic F45.22
- bone M89.9
- brachial plexus G54.0
- branched-chain amino-acid metabolism E71.2
- breast N64.9
- Briquet's F45.0
- bullous, in diseases classified elsewhere L14
- cardiac, functional I51.89
- carnitine metabolism E71.40
- cartilage M94.9
- catatonia (due to known physiological condition) (with another mental disorder) F06.1
- catatonic NOS F06.1
- central auditory processing H93.25
- character NOS F60.9
- childhood disintegrative NEC F84.3
- cholesterol and bile acid metabolism E78.70
- choroid H31.9
- citrate metabolism NEC E74.829
- citrate transporter, SLC13A5 E74.820
- coagulation (factor) D68.9
- coccyx NEC M53.3
- cognitive F09
- communication F80.9
- conduct (childhood) F91.9
- conduction, heart I45.9
- congenital glycosylation (CDG) E74.89
- conjunctiva H11.9
- connective tissue, localized L94.9
- cornea H18.9
- corpus cavernosum N48.9
- Cyclin-Dependent Kinase-Like 5 Deficiency (CDKL5) G40.42
- cyclothymic F34.0
- defiant oppositional F91.3
- delusional (persistent) (systematized) F22
- depersonalization F48.1
- depressive F32.A
- developmental F89
- diaphragm J98.6
- digestive (system) K92.9
- disc (intervertebral) M51.9
- disinhibited attachment (childhood) F94.2
- disintegrative, childhood NEC F84.3
- disruptive F91.9
- dissocial personality F60.2
- dissociative F44.9
- dream anxiety F51.5
- drug induced hemorrhagic D68.32
- drug related F19.99
- dysmorphic body F45.22
- dysthymic F34.1
- ear H93.9
- eating (adult) (psychogenic) F50.9
- electrolyte (balance) NEC E87.8
- elimination, transepidermal L87.9
- emotional (persistent) F34.9
- endocrine E34.9
- erectile (male) (organic) N52.9
- esophagus K22.9
- eustachian tube H69.9
- exhibitionistic F65.2
- extrapyramidal G25.9
- eye H57.9
- eyelid H02.9
- feeding (infant or child) R63.30
- feigned (with obvious motivation) Z76.5
- fetishistic F65.0
- fibroblastic M72.9
- fluid balance E87.8
- follicular (skin) L73.9
- FOXG1-related QA0.0151
- frotteuristic F65.81
- fructose metabolism E74.10
- functional polymorphonuclear neutrophils D71.9
- gallbladder, biliary tract and pancreas in diseases classified elsewhere K87
- gambling F63.0
- gamma aminobutyric acid (GABA) metabolism E72.81
- gamma-glutamyl cycle E72.89
- gastric (functional) K31.9
- gastrointestinal (functional) NOS K92.9
- gender incongruence F64.9
- gender-identity or -role F64.9
- genito-pelvic pain penetration F52.6
- globe H44.9
- glomerular (in) N05.9
- gluconeogenesis E74.4
- glucose transport E74.819
- glycine metabolism E72.50
- glycoprotein metabolism E77.9
- habit (and impulse) F63.9
- heart action I49.9
- hematological D75.9
- hematopoietic organs D75.9
- hemorrhagic NEC D69.9
- histidine metabolism E70.40
- hoarding F42.3
- hyperleucine-isoleucinemia E71.19
- hypervalinemia E71.19
- hypoactive sexual desire F52.0
- hypochondriacal F45.20
- immune mechanism (immunity) D89.9
- impaired renal tubular function N25.9
- impulse (control) F63.9
- integument, newborn P83.9
- intermittent explosive F63.81
- involuntary emotional expression (IEED) F48.2
- iris H21.9
- iron metabolism E83.10
- isovaleric acidemia E71.110
- jaw, developmental M27.0
- joint M25.9
- ketone metabolism E71.32
- kidney N28.9
- lacrimal system H04.9
- lactation NEC O92.79
- language (developmental) F80.9
- late luteal phase dysphoric N94.89
- learning (specific) F81.9
- lens H27.9
- ligament M24.20
- liver K76.9
- lung, interstitial, drug-induced J70.4
- lymphoproliferative, post-transplant (PTLD) D47.Z1
- lysine and hydroxylysine metabolism E72.3
- major neurocognitive F03
- manic F30.9
- meninges, specified type NEC G96.198
- menopausal N95.9
- menstrual N92.6
- mental (or behavioral) (nonpsychotic) F99
- metabolic, amino acid, transitory, newborn P74.8
- metabolism NOS E88.9
- methylmalonic acidemia E71.120
- micturition NEC R39.198
- mild neurocognitive G31.84
- mitochondrial metabolism E88.40
- mood F39
- movement G25.9
- multiple personality F44.81
- muscle M62.9
- myoneural G70.9
- myotonic NEC G71.19
- nail, in diseases classified elsewhere L62
- neonatal onset multisystemic inflammatory (NOMID) M04.2
- nerve G58.9
- nervous system G98.8
- neurocognitive R41.9
- neurodevelopmental F89
- neurohypophysis NEC E23.3
- neurological NEC R29.818
- neuromuscular G70.9
- neurotic F48.9
- neutrophil, polymorphonuclear D71.9
- nightmare F51.5
- nose J34.9
- obsessive-compulsive F42.9
- odontogenesis NOS K00.9
- oppositional defiant F91.3
- orbit H05.9
- orgasmic (female) F52.31
- ornithine metabolism E72.4
- overanxious F41.1
- pancreatic internal secretion E16.9
- panic F41.0
- papulosquamous L44.9
- paranoid F22
- paraphilic F65.9
- parathyroid (gland) E21.5
- parietoalveolar NEC J84.09
- paroxysmal, mixed R56.9
- patella M22.9
- patellofemoral M22.2X
- pedophilic F65.4
- pentose phosphate pathway with anemia D55.1
- perception, due to hallucinogens F16.983
- peripheral nervous system NEC G64
- peroxisomal E71.50
- personality F60.9
- pervasive, developmental F84.9
- phobic anxiety, childhood F40.8
- phosphate-losing tubular N25.0
- pigmentation L81.9
- pinna (noninfective) H61.10
- pituitary gland E23.7
- platelet-activating anti-PF4, specified NEC D75.84
- platelets D69.19
- plexus G54.9
- polymorphonuclear neutrophils D71.9
- postconcussional F07.81
- posthallucinogen perception F16.983
- postmenopausal N95.9
- post-transplant lymphoproliferative D47.Z1
- post-traumatic stress (PTSD) F43.10
- premenstrual dysphoric (PMDD) F32.81
- prepuce N47.8
- propionic acidemia E71.121
- prostate N42.9
- psychogenic NOS F45.9
- psychological F99
- psychomotor NEC F44.4
- psychosexual F65.9
- puberty E30.9
- purine metabolism E79.9
- pyrimidine metabolism E79.9
- pyruvate metabolism E74.4
- reactive attachment (childhood) F94.1
- reading R48.0
- receptive language F80.2
- receptor, hormonal, peripheral E34.50
- recurrent brief depressive F33.8
- reflex R29.2
- refraction H52.7
- relationship F68.8
- REM sleep behavior G47.52
- renal function, impaired (tubular) N25.9
- resonance R49.9
- retina H35.9
- retroperitoneal K68.9
- right hemisphere organic affective F07.89
- rumination (infant or child) (in remission) F98.21
- sacrum, sacrococcygeal NEC M53.3
- schizoaffective F25.9
- schizoid of childhood F84.5
- schizophrenia spectrum and other psychotic disorder F29
- schizophreniform F20.81
- schizotypal (personality) F21
- secretion, thyrocalcitonin E07.0
- seizure G40.909
- semantic pragmatic F80.89
- sense of smell R43.1
- separation anxiety, of childhood F93.0
- shyness, of childhood and adolescence F40.10
- sibling rivalry F93.8
- sinus (nasal) J34.9
- skin L98.9
- SLC13A5 Citrate Transporter Disorder E74.820
- sleep G47.9
- sleep-wake pattern or schedule G47.9
- soft tissue M79.9
- somatic symptom F45.1
- somatization F45.0
- somatoform F45.9
- speech R47.9
- speech-sound F80.0
- spelling (specific) F81.81
- stereotyped, habit or movement F98.4
- stress F43.9
- sulfur-bearing amino-acid metabolism E72.10
- sweat gland (eccrine) L74.9
- synovium M67.90
- temperature regulation, newborn P81.9
- temporomandibular joint M26.60
- tendon M67.90
- thoracic root (nerve) NEC G54.3
- thyrocalcitonin hypersecretion E07.0
- thyroid (gland) E07.9
- tooth K08.9
- Tourette's F95.2
- trance and possession F44.89
- transvestic F65.1
- trauma and stressor-related NOS F43.9
- tryptophan metabolism E70.5
- tubular, phosphate-losing N25.0
- tubulo-renal function, impaired N25.9
- tympanic membrane H73.9
- unsocialized aggressive F91.1
- urea cycle metabolism E72.20
- ureter (in) N28.9
- urethra N36.9
- urinary system N39.9
- vestibular function H81.9
- vision, binocular H53.30
- vitreous body H43.9
- voice R49.9
- voyeuristic F65.3
- white blood cells D72.9
- withdrawing, child or adolescent F40.10
Index entries, exactly as the book files them. This says they are listed together — not that any of them is documented in your chart.
How to use this page
Everything the published sources say about one code, on one page.
- Read the Excludes1 block first — it is the one that stops you coding this at all alongside another code.
- Excludes2, Code first, Use additional and Includes follow. A note inherited from a parent category is labelled with the category it came from, so you can see why it applies.
- Official Guidelines sit below. "Guidelines naming this code" cite the code or a range containing it; "Chapter guidance" is the general guidance for its chapter and is the weaker signal.
- Guideline text is quoted verbatim with its section number and page, so you can check it against the published document.
- Risk-model chips show which published CMS models map this code.
What this page does not do
- Guidance is quoted, never paraphrased — a paraphrase of a coding rule is a different rule.
- Medication candidates, where shown, are matched by condition *name* and are offered as candidates for you to judge. They are not "the drugs for this code".
Exclusions16never code together
- autoimmune disease (systemic) NOS (M35.9)M35.9
- certain conditions originating in the perinatal period (P00-P96)P00-P96
- complications of pregnancy, childbirth and the puerperium (O00-O9A)O00-O9A
- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)Q00-Q99
- endocrine, nutritional and metabolic diseases (E00-E88)E00-E88
- human immunodeficiency virus [HIV] disease (B20)B20
- injury, poisoning and certain other consequences of external causes (S00-T88)S00-T88
- neoplasms (C00-D49)C00-D49
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)R00-R94
Excludes1 — never code together. The excluded condition and this one are mutually exclusive.
Excludes2 — not included here, but the patient may have both. Code both when documented.
Instructional notes3
- defects in the complement system
- immunodeficiency disorders, except human immunodeficiency virus [HIV] disease
- sarcoidosis
Official Guidelines1names this code
ICD-10-CM Official Guidelines for Coding and Reporting, quoted in full. Published by CMS and NCHS; in the public domain.
Index entries leading here4
Alongside this code4same parent — D89.8
Additional references
Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.